Alfred Daramola

Alfred Daramola is a Commercial Analytics Manager at Neurocrine Biosciences, a position held since October 2024. Prior experience includes a significant tenure at Biogen, where Alfred Daramola participated in the MBA Leadership Development Program, focusing on forecasting, insights, and analytics, as well as commercial operations and marketing for the launch of Zurzuvae and the non-personal promotion of VUMERITY. Alfred Daramola's earlier roles include a research technician at Baylor College of Medicine, contributing to projects related to pediatric acute myeloid leukemia, and an associate scientist at Base Pair Biotechnologies, Inc., working with the SELEX team. Alfred Daramola obtained an MBA from Mays Business School at Texas A&M University and a Master's degree in Biotechnology from the University of Houston-Clear Lake.